EMCDDA Home
  • EN
Search

Table TDI-36. Primary amphetamine use among new clients entering treatment (%), 2003 to 2008

Country200320042005200620072008
Czech Republic55.058.459.761.763.662.7
Denmark10.412.910.214.913.514.2
Ireland1.00.91.10.91.01.0
Latvia14.024.522.622.324.024.5
Hungary(1)4.04.45.65.310.210.4
Netherlands4.86.07.07.56.97.1
Slovakia24.631.630.132.233.239.1
Finland31.728.027.622.022.924.4
Sweden30.727.732.733.027.724.8

Notes:

 Percentages are of new clients with known primary drug.               

 Only countries with available data are shown               

 (1) The source of the data has changed in 2007: from “Hungarian National Focal Point – National statistical programme” (1997-2006) to “Hungarian National Focal Point – TDI data collection” (2007). The change limits the comparability of the 2007 data to previous years data. 

 See also ‘General notes for interpreting data’ on the Explanatory notes and help page.   

Sources:

 Reitox national reports 2009 — Standard table 34 See also Table TDI-4 and Table TDI-5 and see Table TDI-0] for details on sources.   

(see the help page for information about formats etc.)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 14 July 2010